In the study of Tsujie et al., significant reduction in tumor growth was obtained in colon-26 and 4T1 tumors after the treatment with anti-endoglin antibodies SN6j; 5 times treatment was used in colon-26 and 4 times in 4T1 breast cancer model [23]. The gene discussed is ENG; the disease is breast cancer.